Listed

Cineverse Corp.: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Nov 14, 2025 and accepted by EDGAR at Nov 14, 2025, 17:31 ET.

Share

Management's discussion and analysis

As filed, 22,454 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion and analysis should be read in conjunction with our historical Condensed Consolidated Financial Statements and the related notes included elsewhere in this report.

This report contains forward-looking statements within the meaning of the federal securities laws. These include statements about our expectations, beliefs, intentions or strategies for the future, which are indicated by words or phrases such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “will,” “estimates,” and similar words. Forward-looking statements represent, as of the date of this report, our judgment relating to, among other things, future results of operations, growth plans, sales, capital requirements and general industry and business conditions applicable to us. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, assumptions and other factors, some of which are beyond our control that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

Business Overview

Cineverse Corp. (“Cineverse”, “us”, “our”, "we", and “Company” refers to Cineverse Corp. and its subsidiaries unless the context otherwise requires) was incorporated in Delaware on March 31, 2000.

The Company has a long legacy in using technology to transform the entertainment industry and played a pioneering role in transitioning movie screens from traditional analog film prints to digital distribution. Over the past several years, Cineverse has transformed itself from being a digital cinema equipment and physical content distributor to a leading independent streaming company.

Cineverse is a streaming technology and entertainment company with its core business operating as (i) a portfolio of owned and operated streaming channels with enthusiast fan bases; (ii) a large-scale global aggregator and full-service distributor of feature films and television programs; and (iii) a proprietary technology software-as-a-service platform for over-the-top (“OTT”) app development and content distribution through subscription video on demand ("SVOD"), dedicated ad-supported video on demand ("AVOD"), ad-supported streaming linear ("FAST") channels, social video streaming services, and audio podcasts. Our streaming channels reach audiences in several distinct ways: direct-to-consumer, through these major application platforms, and through third-party distributors of content on platforms.

The Company’s streaming technology platform, known as Matchpoint™, is a software-based streaming operating platform which provides clients with AVOD, SVOD, transactional video on demand ("TVOD") and linear capabilities, automates the distribution of content, and features a robust data analytics platform.

We distribute products for major brands such as Hallmark, ITV, Nelvana, ZDF, Konami, NFL and Highlander, as well as international and domestic content creators, movie producers, television producers and other short-form digital content producers. We collaborate with producers, major brands and other content owners to market, source, curate and distribute quality content to targeted audiences through (i) existing and emerging digital home entertainment platforms, including but not limited to Apple iTunes, Amazon Prime, Netflix, Hulu, Xbox, Pluto, and Tubi, as well as (ii) physical goods, including DVD and Blu-ray Discs.

Financial Condition and Liquidity

As of September 30, 2025, the Company has an accumulated deficit of $510.2 million and negative working capital of $1.3 million. For the three and six months ended September 30, 2025, the Company had a net loss attributable to the Company's common stock, par value $0.001 per share (the "Common Stock") holders of $9.3 million. Net cash used in operating activities for the six months ended September 30, 2025 was $21.7 million, which included $4.2 million of incremental investment in our content portfolio via advances or minimum guarantee payouts. We may continue to generate net losses for the foreseeable future. During the six months ended September 30, 2025, 1.9 million warrants were exercised for net proceeds of $5.8 million.

The Company is party to a Loan, Guaranty, and Security Agreement, as amended on April 8, 2025, with East West Bank (the "Line of Credit Facility") providing for borrowings of up to $12.5 million and expandable to $15.0 million, guaranteed by substantially all of our material subsidiaries and secured by substantially all of our and our subsidiaries’ assets. As of September 30, 2025, $6.6 million was outstanding on the Line of Credit Facility.

The Company will continue to invest in content development and acquisitions, from which it believes it will obtain an appropriate return on its investment. As of September 30, 2025 and March 31, 2025, short-term content advances were $5.4 million and $6.7 million, respectively, and content advances, net of current portion, were $7.9 million and $4.1 million, respectively.

Our capital requirements will depend on many factors, and we may need to use existing capital resources and/or undertake equity or debt offerings, if necessary and opportunistically available, for further capital needs. We believe our cash and cash equivalents and availability under our Line of Credit Facility as of September 30, 2025 will be sufficient to support our operations for at least twelve months from the filing of this report.

Critical Accounting Estimates

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events and apply judgments that affect the reported amounts of assets, liabilities, revenue, expenses and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors that management believes to be relevant at the time our Condensed Consolidated Financial Statements are prepared. On a regular basis, management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

Our significant accounting policies are discussed in Note 2 – Basis of Presentation and Summary of Significant Accounting Policies, of the Notes to the Condensed Consolidated Financial Statements, included in Item 1, Condensed Consolidated Financial Statements (Unaudited), of this Quarterly Report on Form 10-Q. Management believes that these policies are the most critical to aid in fully understanding and evaluating our reported financial results, and they require management’s most difficult, subjective or complex judgments, resulting from the need to make estimates about the effect of matters that are inherently uncertain. Management has reviewed these critical accounting estimates and related disclosures with the Audit Committee of our Board of Directors.

Results of Operations for the three months ended September 30, 2025 and 2024 (unaudited) (in thousands):

Revenue

For the Three Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Streaming and digital $9,558 $10,089 (531) (5)% 77% 80%
Base distribution 1,837 1,321 516 39% 15% 10%
Podcast and other 946 1,273 (327) (26)% 8% 10%
Other and non-recurring 16 56 (40) (71)% 0% 0%
Total Revenue $12,357 $12,739 $(382) (3)% 100% 100%

Streaming and digital revenue for the three months ended September 30, 2025 decreased by $0.5 million, primarily due to lower licensing revenue. The same period in 2024 included $1.6 million license fee revenue related to the licensing of the Dog Whisperer content. In the prior-year quarter, the Company recorded $1.6 million from a Dog Whisperer licensing agreement, while this quarter includes a recently signed $1.1 million licensing deal for The Toxic Avenger Unrated that will be recognized in future periods. Excluding these timing effects, performance across the Company’s core business lines continued to show solid underlying growth.

The $0.5 million increase in Base distribution revenue for the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily attributable to approximately $1.1 million of revenue recognized from the theatrical release of Toxic Avenger and the final theatrical revenue for Terrifier 3, offset by a decrease in physical sales.

Podcast and other revenue declined by $0.3 million during the three months ended September 30, 2025, compared to same period in 2024 due to lower podcast direct advertising.

Direct Operating Expenses

For the Three Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Direct operating expenses $5,214 $6,262 $(1,048) (17)% 42% 49%

The $1.0 million decrease in Direct operating expenses for the three months ended September 30, 2025 was primarily driven by lower variable costs compared to the prior year quarter, including royalty expense, platform fees, manufacturing, freight, and fulfillment charges, offset by an increase in theatrical distribution fees related to Toxic Avenger.

Selling, General and Administrative Expenses

For the Three Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Compensation expense $5,253 $4,088 $1,165 28% 43% 32%
Corporate expenses 1,486 732 754 103% 12% 6%
Share-based compensation 494 503 (9) (2)% 4% 4%
Marketing expenses 2,849 22 2,827 12850% 23% 0%
Other operating expenses 1,325 1,019 306 30% 11% 8%
Selling, General and Administrative $11,407 $6,364 $5,043 79% 92% 50%

For the three months ended September 30, 2025 compared to three months ended September 30, 2024, Compensation expense increased by $1.2 million due to increased employee headcount. Corporate expenses increased by $0.8 million reflecting higher professional services and legal expenses associated with strategic business and content acquisitions. Marketing expenses increased by $2.8 million primarily due to Toxic Avenger. For the three months ended September 30, 2024, $0.3 million Marketing expenses were included in Direct operating expenses.

Depreciation and Amortization Expense

For the Three Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Amortization of intangible assets $1,040 $815 $225 28% 8% 6%
Depreciation of property and equipment 106 159 (53) (33)% 1% 1%
Depreciation and Amortization $1,146 $974 $172 18% 9% 7%

Amortization expense increased during the three months ended September 30, 2025 compared to the prior year quarter primarily due to increased capitalized content costs.

Interest Expense, Net

For the three months ended September 30, 2025, interest expense decreased by $0.2 million to $0.1 million compared to the prior year quarter. The decrease is primarily the result of a lower average balance on the Line of Credit Facility during the quarter compared to the prior year quarter.

Results of Operations for the six months ended September 30, 2025 and 2024 (unaudited) (in thousands):

Revenues

For the Six Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Streaming and digital $18,663 $17,792 $871 5% 79% 81%
Base distribution 2,860 1,672 1,188 71% 12% 8%
Podcast and other 1,935 2,316 (381) (16)% 8% 11%
Other and non-recurring 18 86 (68) (79)% 0% 0%
Total Revenue $23,476 $21,866 $1,610 7% 100% 100%

Streaming and digital revenue for the six months ended September 30, 2025 increased by $0.9 million compared to the same period in 2024, primarily driven by $0.5 million from the digital release of Terrifier 3, and continued growth across the Company’s subscription-based platforms.

Podcast and other revenue declined by $0.4 million during the six months ended September 30, 2025 compared to same period in 2024, due to direct advertising offset by an increase in Matchpoint™ revenue.

The $1.2 million increase in Base distribution revenue for the six months ended September 30, 2025, compared to the same period in 2024, due to the theatrical release of Toxic Avenger and final theatrical revenue for Terrifier 3.

Direct Operating Expenses

For the Six Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Direct operating expenses $10,021 $10,741 $(720) (7)% 43% 49%

The decrease of $0.7 million in Direct Operating Expenses for the six months ended September 30, 2025, compared to the six months ended September 30, 2024 was primarily driven by lower variable costs, including royalty expenses, platform fees, and freight and fulfillment charges. The reduction also reflects higher recoupements on our content advances resulting in lower provision for royalty advance allowance. These decreases were partially offset by increased theatrical distribution fees related to Toxic Avenger and licensor costs.

Selling, General and Administrative Expenses

For the Six Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Compensation expense $10,690 $8,139 $2,551 31% 46% 37%
Corporate expenses 2,682 1,744 938 54% 11% 8%
Share-based compensation 912 973 (61) (6)% 4% 4%
Marketing expenses 3,312 44 3,268 7427% 14% 0%
Other operating expenses 2,763 2,027 736 36% 12% 9%
Selling, General and Administrative $20,359 $12,927 $7,432 57% 87% 59%

For the six months ended September 30, 2025 compared to six months ended September 30, 2024, Compensation expenses increased by $2.6 million due to increased employee headcount. Corporate expenses increased by $0.9 million reflecting higher professional services and legal expenses associated with strategic business and content acquisitions. Marketing expenses increased by primarily due to Toxic Avenger. For the six months ended September 30, 2024, $0.3 million Marketing expenses were included in Direct operating expenses. Other operating expenses increased by $0.7 million primarily due to increased administrative costs.

Depreciation and Amortization Expense

For the Six Months Ended September 30, 2025 2024 $ Change % Change As a % of Revenue 2025 2024
Amortization of intangible assets $1,997 $1,524 $473 31% 9% 7%
Depreciation of property and equipment 211 313 (102) (33)% 1% 1%
Depreciation and Amortization $2,208 $1,837 $371 20% 9% 8%

Amortization expense increased by $0.5 million during the six months ended September 30, 2025, compared to 2024, primarily due to increased capitalized content costs.

Interest Expense, Net

For the six months ended September 30, 2025 compared to the same period of 2024, interest expense decreased by $0.9 million primarily due to higher outstanding debt balances and increased interest rates in 2024, along with a $0.4 million discount to accrued interest provided by the Terrifier 3 lender during the six months ended September 30, 2025 in return for the final payment made in the quarter.

Adjusted EBITDA

We define Adjusted EBITDA to be earnings before interest, taxes, depreciation and amortization, stock-based compensation expense, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including our stockholders, as a valuable financial metric.

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net income (loss) from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net income (loss) from continuing operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to net income (loss) from operations as an indicator of performance or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our Condensed Consolidated Financial Statements prepared in accordance with GAAP.

Following is the reconciliation of our consolidated net (loss) income to Adjusted EBITDA (in thousands):

For the Three Months Ended September 30, 2025 2024 For the Six Months Ended September 30, 2025 2024
Net loss $(5,545) $(1,203) $(9,061) $(4,253)
Add Back:
Income tax expense 20 6 34 13
Depreciation and amortization ⁽¹⁾ 1,275 974 2,422 1,837
Interest expense (income) 147 337 (131) 768
Stock-based compensation 494 503 912 973
Other (income) expense, net (32) (1) 46 (167)
Net income attributable to noncontrolling interest (44) (84) (88) (106)
Other transaction costs ⁽²⁾ — — 47 27
Adjusted EBITDA $(3,685) $532 $(5,819) $(908)

(1) - Includes $129 thousand and $214 thousand of amortization included in direct operating expenses on our Consolidated Statements of Operations for the three and six months ended September 30, 2025, respectively.

(2) - Primarily includes employee severance related costs.

Cash Flow

Changes in our cash flows were as follows (in thousands):

For the Six Months Ended September 30, 2025 2024
Net cash used in operating activities $(21,695) $(2,429)
Net cash used in investing activities (857) (820)
Net cash provided by financing activities 10,964 463
Net Change in Cash and Cash Equivalents $(11,588) $(2,786)

For the six months ended September 30, 2025, net cash used in operating activities was primarily driven by loss from operations, excluding non-cash expenses such as depreciation, amortization and stock-based compensation, and other changes in working capital. Specifically, the adjustments are primarily driven by net cash outflows related to content advances made to partners for which initial expenditures are generally recovered within six to twelve months and operating prepayments and a decrease in accounts payable and accrued expenses. Operating cash flows are typically seasonally lower during the first two fiscal quarters and higher during our fiscal third and fourth quarters, resulting from revenues earned during the holiday season.

Cash used in investing activities is primarily related to expenditures towards long-lived intangible and fixed assets, along with strategic acquisitions.

Cash flows from financing were primarily attributable to proceeds under the Line of Credit Facility, net of payments, and proceeds from common stock warrant exercises.

For the six months ended September 30, 2024, net cash used in operating activities was primarily driven by loss from operations, excluding non-cash expenses such as depreciation, amortization, reserve for credit losses and stock-based compensation, including capitalized content spend and other changes in working capital. Operating cash flows are typically seasonally lower during the first two fiscal quarters and higher during our fiscal third and fourth quarters, resulting from revenues earned during the holiday season.

Off-balance sheet arrangements

We are not a party to any off-balance sheet arrangements other than as discussed in Note 2 – Basis of Presentation and Summary of Significant Accounting Policies, Basis of Presentation and Consolidation and Note 3 - Other Interests to the Condensed Consolidated Financial Statements included in Item 1 of this Quarterly Report on Form 10-Q, we hold a 100% equity interest in CDF2 Holdings, which is an unconsolidated variable interest entity (“VIE”), which wholly owns Cinedigm Digital Funding 2, LLC; however, we are not the primary beneficiary of the VIE.

Controls and procedures

As filed, 2,063 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Definition and Limitations of Disclosure Controls and Procedures

Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) are designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act is (i) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and (ii) accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosures.

Evaluation of Disclosure Controls and Procedures

The management of the Company, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in the Exchange Act), as of September 30, 2025. Based on such evaluation, our principal executive officer and principal financial and accounting officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported, on a timely basis, and (ii) accumulated and communicated to the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures as of September 30, 2025.

Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s internal control over financial reporting during the three months ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risk factors

As filed, 152 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There have been no material changes to the Risk Factors disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-07-01 to 2025-09-30$12.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2025-04-01 to 2025-09-30$23.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Selling, general and administrative3 months2025-07-01 to 2025-09-30$11.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2025-04-01 to 2025-09-30$20.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2025-07-01 to 2025-09-30−$5.4mus-gaap:OperatingIncomeLoss
Operating income6 months2025-04-01 to 2025-09-30−$9.1mus-gaap:OperatingIncomeLoss
Income tax3 months2025-07-01 to 2025-09-30$20.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2025-04-01 to 2025-09-30$34.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-07-01 to 2025-09-30−$5.5mus-gaap:NetIncomeLoss
Net income6 months2025-04-01 to 2025-09-30−$9.1mus-gaap:ProfitLoss
Diluted EPS3 months2025-07-01 to 2025-09-30−$0.31us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2025-04-01 to 2025-09-30−$0.53us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-07-01 to 2025-09-30−$0.31us-gaap:EarningsPerShareBasic
Basic EPS6 months2025-04-01 to 2025-09-30−$0.53us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-07-01 to 2025-09-3018,447,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2025-04-01 to 2025-09-3017,720,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2025-04-01 to 2025-09-30−$21.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Share repurchases6 months2025-04-01 to 2025-09-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-09-30$2.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-09-30$23.3mus-gaap:AssetsCurrent
Total assetsAt period end2025-09-30$61.9mus-gaap:Assets
Current liabilitiesAt period end2025-09-30$24.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-09-30$24.8mus-gaap:Liabilities
Shareholders' equityAt period end2025-09-30$38.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-25-283349. Last ingested by Listed: Oct 29, 2026, 04:32 ET. Listed shows no prices and gives no investment advice.